2-Methoxy-3-(tributylstannyl)pyrazine
Product Information
Molecular Formula
C17H32N2OSn
Molecular Weight
399.15
Description
2-Methoxy-3-(tributylstannyl)pyrazine is a compound highly sought-after in the realm of biomedicine due to its immense potential for therapeutic applications. It showcases formidable anti-inflammatory and antioxidant attributes. This renders it an exceedingly promising contender for mitigating inflammatory afflictions like arthritis. Further still, the compound's propitious nature extends to the arena of medicinal innovation, where it demonstrates prospects for combating cancer, neurodegenerative maladies, and a plethora of oxidative stress and inflammation related ailments.
Synonyms
2-Methoxy-3-(tributylstannyl)pyrazine
IUPAC Name
tributyl-(3-methoxypyrazin-2-yl)stannane
SMILES
CCCC[Sn](CCCC)(CCCC)C1=NC=CN=C1OC
InChI
InChI=1S/C5H5N2O.3C4H9.Sn/c1-8-5-4-6-2-3-7-53*1-3-4-2/h2-3H,1H33*1,3-4H2,2H3
InChI Key
MEKPDHIMYRRQFX-IYERMVBKAL
Flash Point
>230 °F
Purity
97%
Density
1.167 g/mL at 25 °C
Refractive Index
n20/D 1.515
Safety Information
Hazards
H301-H312-H315-H319-H372-H410
Precautionary Statement
P273-P280-P301 + P310-P305 + P351 + P338-P314-P501
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
11
Exact Mass
400.153666 g/mol
Monoisotopic Mass
400.153666 g/mol
Topological Polar Surface Area
35Ų
Heavy Atom Count
21
Formal Charge
0
Complexity
241
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| AU-2017384481-A1 | Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as PDE1 inhibitors | 2016-12-22 |
| CA-3046588-A1 | Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as pde1 inhibitors | 2016-12-22 |
| EP-3558988-A1 | Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as pde1 inhibitors | 2016-12-22 |
| JP-2020502230-A | Pyrazolo [3,4-b] pyridine and imidazo [1,5-b] pyridazine as PDE1 inhibitors | 2016-12-22 |
| KR-20190095301-A | Pyrazolo [3,4-b] pyridine and imidazo [1,5-b] pyridazine as PDE1 inhibitors | 2016-12-22 |
| US-10351561-B2 | Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as PDE1 inhibitors | 2016-12-22 |
| US-10689379-B2 | Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors | 2016-12-22 |
| US-2018179200-A1 | PYRAZOLO[3,4-b]PYRIDINES AND IMIDAZO[1,5-b]PYRIDAZINES AS PDE1 INHIBITORS | 2016-12-22 |
| US-2019352302-A1 | Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as pde1 inhibitors | 2016-12-22 |
| WO-2018115067-A1 | Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as pde1 inhibitors | 2016-12-22 |
